ダイト(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4577/E24187 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2025/02/07 | 日証協 | 114,299株 | -7.82% | 75,770株 | -53.39% | 138,408株 | +0.03% | 52,719株 | +6.07% |
2025/01/31 | 日証協 | 123,995株 | +15.58% | 162,551株 | +39.49% | 138,365株 | +3.4% | 49,701株 | +155.51% |
2025/01/24 | 日証協 | 107,277株 | +13.2% | 116,531株 | -22.52% | 133,810株 | +0.31% | 19,452株 | -26.6% |
2025/01/17 | 日証協 | 94,771株 | +1.94% | 150,392株 | +74.79% | 133,399株 | +0.37% | 26,500株 | -25.43% |
2025/01/10 | 日証協 | 92,971株 | +22.73% | 86,043株 | +1012.82% | 132,909株 | +16.32% | 35,538株 | +503.16% |
2024/12/30 | 日証協 | 75,750株 | +0.8% | 7,732株 | -93.67% | 114,263株 | +0.27% | 5,892株 | -25.12% |
2024/12/27 | 日証協 | 75,150株 | -7.38% | 122,213株 | +4900.53% | 113,957株 | +0.62% | 7,869株 | -56.33% |
2024/12/20 | 日証協 | 81,140株 | -26.26% | 2,444株 | -98.09% | 113,257株 | -28.2% | 18,019株 | -3.85% |
2024/12/13 | 日証協 | 110,040株 | -36.13% | 127,932株 | +19.32% | 157,738株 | -27.34% | 18,740株 | -60.31% |
2024/12/06 | 日証協 | 172,287株 | -3.84% | 107,216株 | -45.63% | 217,095株 | +38.21% | 47,215株 | -58.68% |
2024/11/29 | 日証協 | 179,159株 | +60.82% | 197,204株 | +351.77% | 157,074株 | -14.77% | 114,275株 | +119.48% |
2024/11/22 | 日証協 | 111,402株 | -25.74% | 43,651株 | -51.2% | 184,297株 | +7.71% | 52,067株 | +11.13% |
2024/11/15 | 日証協 | 150,007株 | +47.96% | 89,441株 | +21.54% | 171,098株 | +44.3% | 46,852株 | -30.56% |
2024/11/08 | 日証協 | 101,382株 | +0.4% | 73,590株 | +5.36% | 118,574株 | +2.33% | 67,473株 | +219.78% |
2024/11/01 | 日証協 | 100,982株 | -6.1% | 69,848株 | -12.1% | 115,873株 | -2.33% | 21,100株 | -17.85% |
2024/10/25 | 日証協 | 107,538株 | -21.31% | 79,461株 | +3.04% | 118,642株 | -0.25% | 25,684株 | -12.64% |
2024/10/18 | 日証協 | 136,653株 | -2.72% | 77,114株 | -45.19% | 118,942株 | -2.46% | 29,399株 | -28.32% |
2024/10/11 | 日証協 | 140,473株 | -57.38% | 140,681株 | -17.1% | 121,943株 | -48.8% | 41,013株 | +55.18% |
2024/10/04 | 日証協 | 329,610株 | -1.34% | 169,706株 | +34.33% | 238,167株 | -2.7% | 26,430株 | +20.68% |
※株式分割は考慮していませんのでご注意ください。
Page Top